"Not So Different": The Year in US Regulatory Activity for Biosimilars

When it comes to US biosimilars, 2019 was a busy year for regulatory activity. This week on the podcast, we're rounding up the key developments of the year.

When it comes to US biosimilars, 2019 was a busy year for regulatory activity. This week on the podcast, we're rounding up the key developments of the year.

Related Videos
Here are the top 5 biosimilar articles for the week of February 13th, 2023.
Ian Henshaw
Julie M. Reed
Sonia T. Oskouei, PharmD, BCMAS, DPLA0
Eric Tichy, PharmD, MBA
Julie M. Reed
Julie M. Reed
Eric Tichy, PharmD, MBA
Jeffrey Casberg
Gillian Woollett, MA, Dphil
Related Content
© 2023 MJH Life Sciences

All rights reserved.